• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

Treating older people with diabetes is challenging due to multiple medical comorbidities that might interfere with patients' ...

RAs, originally for diabetes, may impact brain health, finding potential benefits for dementia and addiction but inconsistent ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Alcohol use disorder is a prevalent and major but preventable cause of morbidity and mortality worldwide, causing several ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

We recently compiled a list of the 14 Best Large Cap Dividend Growth Stocks To Buy Now. In this article, we are going to take ...

Commercials run by the telehealth company Hims & Hers have been placed under the microscope as lawmakers are calling out ...

As the body of research expands on the potential of glucagon-like peptide-1 receptor agonists to address various health ...

The table below is a review of notable updates that occurred in January 2025 for investigational products in development.